This is a news story, published by Yahoo Finance, that relates primarily to Eli Lilly news.
For more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsFor more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
resistance. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Stock Market Game news, stock news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
stocksBenzinga
•53% Informative
Eli Lilly hit resistance when it reached the $ 955 level in July .
Then after a sell-off and reversal, it ran into resistance again at the same price in August .
Many of the people who bought Lilly when it was at resistance in July regretted their decision to do so when the price moved lower.
VR Score
28
Informative language
14
Neutral language
51
Article tone
informal
Language
English
Language complexity
31
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
7
Source diversity
2
Affiliate links
no affiliate links